期刊文献+

1,25-二羟维生素D_3对免疫性血小板减少症模型小鼠的治疗作用 被引量:10

The therapeutic effect of 1,25-dihydroxyvitamin D_3 on ITP mice model
下载PDF
导出
摘要 目的观察并分析1,25-二羟维生素D3对免疫性血小板减少症(ITP)模型小鼠的治疗作用。方法将44只BALB/c小鼠分为正常对照组、模型组和1,25-二羟维生素D3治疗组。模型组经腹腔给予豚鼠抗小鼠血小板血清(GPAPS),治疗组在模型组的基础上经尾静脉注射给予100 ng/d的1,25-二羟维生素D3,正常对照组均给予相同体积的生理盐水经腹腔及尾静脉注射给药。在每次给药后24 h记录体重并采血,测量血小板计数,评价出血倾向。2周后处死小鼠并解剖,取骨髓涂片,镜下计数巨核细胞。从多方面评估1,25-二羟维生素D3对模型小鼠的治疗作用。结果注射第10天开始,1,25-二羟维生素D3治疗组小鼠进食量开始明显增加,精神和反应逐渐恢复;体重、血小板数较模型组明显上升(P<0.05);出血倾向较模型组明显降低(P<0.05);产板巨核细胞数较模型组高,低于正常对照组,而巨核细胞数较模型组低,高于正常对照组,差异有统计学意义。结论 1,25-二羟维生素D3对模型小鼠在一般情况的改善、体重及血小板数的上升、出血倾向的降低和促进骨髓血小板生成等方面表现出一定影响。 Objective To observe and analyze the therapeutic effect of 1,25-dihydroxyvitamin D3 on the immune thrombocytopenia( ITP) model in mice. Methods 44 BALB / c mice were divided into three groups: normal control group,model group and 1,25-dihydroxyvitamin D3 treatment group. The model group was given the GP-APS intraperitoneally,while the treatment group,on the basis of the model group,was administered 100 ng / d of 1,25-dihydroxyvitamin D3 by intravenous injection,and the normal control group was given the same volume of saline through both intraperitoneal and intravenous injection. The mice were taken blood samples after 24 hours of each administration,recorded their weights and measured platelet accounts and bleeding tendencies. After two weeks of injection,the mice were sacrificed and dissected,smeared with the bone marrow that had been taken out,counted the number of megakaryocyte under the microscope. Assessed the therapeutic effect of 1,25-dihydroxyvitamin D3 on the model mice in several aspects. Results From the 10 th day of the injection,the food-intake of the treatment group was markedly increased,the spirit status and reaction was gradually recovered; the body weight and platelet account,compared with the model group,were both significantly increased( P〈0. 05); bleeding tendency evident was markedly decreased( P〈0. 05); the number of the platelet-forming megakaryocyte was higher than the model group and lower than the normal control group,while the number of the megakaryocyte was lower than the model group and higher than the normal control group,the difference was statistically significant. Conclusion 1,25-dihydroxyvitamin D3 shows some influence on the improvement of general status,the rise of body weight and platelet account,the reduction of bleeding tendency and the promotion of platelet's production of the model mice.
出处 《安徽医科大学学报》 CAS 北大核心 2015年第11期1574-1578,共5页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金(编号:1208085MH154)
关键词 免疫性血小板减少症 动物模型 1 25-二羟维生素D3 immune thrombocytopenia animal model 1 25-dihydroxyvitamin D3
  • 相关文献

参考文献17

  • 1Baeke F, Korf H, Overbergh L, et al. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system [J]. J Steroid Biochem Mol Biol,2010,121(1 -2) :221 -7.
  • 2刘飞,杨明珍,李庆生,宋玲,夏雷鸣.1,25-二羟维生素D_3下调Toll样受体7在树突状细胞中的表达[J].安徽医科大学学报,2012,47(8):924-927. 被引量:3
  • 3McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura [J]. Semin Hematol,2000,37 (3) :239 -48.
  • 4Cines D B, Blanchette V S. Immune thrombocytopenic purpura [J]. NEnglJMed,2002,28(13):995-1008.
  • 5Ferreira G B, Overbergh L, Verstuyf A, et al. lc, 25-Di- hydroxyvitamin D3 and its analogs as modulators of human dendrit- ic cells: a comparison dose-titration study [ J]. J Steroid Biochem Mol Biol,2013,136 : 160 - 5.
  • 6褚雨霆,张雅月,侯丽,等.免疫性血小板减少症的免疫学发病机制研究[A].中华中医药学会.血液病中医药防治分论坛论文集[c].中国北京:中华中医药学会,2014:648-52.
  • 7吴宏妍,陈家军,孙宗全,贺斌,张增旺,吴平.重组HSP60蛋白体外对小鼠骨髓树突状细胞功能的影响[J].中国免疫学杂志,2014,30(4):438-441. 被引量:2
  • 8Griffin M D, Lutz W, Phan V A, et al. Dendritic cell modulation by 1 alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D re- ceptor-dependent pathway that promotes a persistent state of imma- turity in vitro and in vivo [J]. Proc Natl Aead Sci U S A,2001,98 (12) :6800 -5.
  • 9van Halteren A G, Tysma O M, van Etten E, et al, lalpha,25-di- hydroxyvitamin D3 or analogue treated dendritic cells modulate hu- man autoreaetive T cells via the selective induction of apoptosis [ J ]. J Autoimmun,2004,23 ( 3 ) :233 - 9.
  • 10Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits dif- ferentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreaetive T cell activation [ J ]. J Immunol, 2000,164 (5) :2405 -11.

二级参考文献16

  • 1Pedersen A W, HolmstrCm K, Jensen S S, et al. Phenotypic and functional markers for 1 alpha,25-dihydroxyvitamin D( 3 )-modified regulatory dendritic ceils [ J]. Clin Exp Immunol, 2009,157 (1) : 48 - 59.
  • 2Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differen- tiation, maturation, and function of human monocyte-derived den- dritic cells[J]. J Immunol, 2000, 164(9) :4443 -51.
  • 3Griffin M D, Lutz W, Phan V A, et al. Dendritic cell modulation by I alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D re- ceptor-dependent pathway that promotes a persistent state of imma- turity in vitro and in vivo[ J]. Proe Natl Acad Sei USA,2001, 98 (12) :6800 - 5.
  • 4Larange A, Antonios D, Pallardy M, et al. TLR7 and TLR8 ago- nists trigger different signaling pathways for human dendritic cell maturation[J]. J Leukoc Biol,2009,85(4) : 673 -83.
  • 5Hill M, Cuturi M C. Negative vaccination by tolerogenic dendritic cells in organ transplantation [ J ]. Curr Opin Organ Transplant, 2010,15(6) :738 -43.
  • 6Sze1es L, Keresztes G, Torocsik D, et al. 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes lead- ing to a tolerogenic dendritic cell phenotype [ J ]. J Immunol, 2009,182(4) :2074 - 83.
  • 7van Halteren A G, Tysma O M, van Etten E,et al. lalpha,25-di- hydroxyvitamin D3 or analogue treated dendritic ceils modulate hu- man autoreactive T cells via the selective induction of apoptosis [J]. J Autoimmun, 2004 ,23(3) :233 -9.
  • 8Unger W W, Laban S, Kleijwegt F S, et al. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1 [ J]. Eur J lmmunol,2009,39 (11): 3147 - 59.
  • 9Yu H, Liu Y, Han J, et al. TLR7 regulates dendritic cell-depend- ent B-cell responses through BIyS in immune thmmbocytopenic purpura[ J]. Eur J Haehaatol, 2011,86( 1 ) :67 -74.
  • 10Hackstein H, Knoche A, Nockher A, et al. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation [ J]. Cell Immunol, 2011,271 (2) :401 - 12.

共引文献3

同被引文献141

引证文献10

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部